Cyclophilin A: promising target in cancer therapy
Cyclophilin A (CypA), a member of the immunophilin family, stands out as the most prevalent among the cyclophilins found in humans. Beyond serving as the intracellular receptor for the immunosuppressive drug cyclosporine A (CsA), CypA exerts critical functions within the cell via its peptidyl-prolyl...
Saved in:
| Main Authors: | Shujuan Jin, Mengjiao Zhang, Xiaoting Qiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2024.2425127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclophilin–CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8
by: Gabor Tajti, et al.
Published: (2025-02-01) -
Elevated levels of cyclophilin A secreted in milk during bovine mastitis
by: Satoru Takanashi, et al.
Published: (2025-01-01) -
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
by: Jennifer Molle, et al.
Published: (2024-12-01) -
The regulatory role of placental extracellular vesicle on trophoblast and endothelial cell functions
by: Kunfeng Bai, et al.
Published: (2025-02-01) -
The origin of human CD20+ T cells: a stolen identity?
by: Marina Rode von Essen, et al.
Published: (2024-11-01)